GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humedix Co Ltd (XKRX:200670) » Definitions » Revenue

Humedix Co (XKRX:200670) Revenue : ₩161,873 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Humedix Co Revenue?

Humedix Co's revenue for the three months ended in Dec. 2024 was ₩37,468 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₩161,873 Mil. Humedix Co's Revenue per Share for the three months ended in Dec. 2024 was ₩3,634.85. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩15,652.42.

Warning Sign:

Humedix Co Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Humedix Co was 1.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Humedix Co's highest 3-Year average Revenue per Share Growth Rate was 22.50% per year. The lowest was 9.90% per year. And the median was 16.60% per year.


Humedix Co Revenue Historical Data

The historical data trend for Humedix Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humedix Co Revenue Chart

Humedix Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98,480.87 110,992.35 123,172.79 152,273.81 161,872.96

Humedix Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,736.01 41,173.72 45,861.58 37,369.60 37,468.06

Competitive Comparison of Humedix Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Humedix Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humedix Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humedix Co's Revenue distribution charts can be found below:

* The bar in red indicates where Humedix Co's Revenue falls into.


;
;

Humedix Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩161,873 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humedix Co  (XKRX:200670) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Humedix Co Revenue Related Terms

Thank you for viewing the detailed overview of Humedix Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Humedix Co Business Description

Traded in Other Exchanges
N/A
Address
268 Anyang Dongan Game Metallurgy, 502 Gwanyang-dong Anyang Mega Valley, Anyang, Gyeonggi, KOR, 431-809
Humedix Co Ltd is a cosmeceutical healthcare company. It supplies Hyaluronic Acid raw material medicine of low molecule and the high molecule which are used in arthritis medicine, eyedrops and in injections for ophthalmology. Further, it is dedicated to the development of new functional materials with diverse physiological activities including vitamin derivatives and supplies a variety of functional materials. In addition, it offers various medical devices, cosmetic and health functional foods. The business activities are primarily carried out through South Korea.

Humedix Co Headlines

No Headlines